I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Dorenbaum, A.
77
results:
Search for persons
X
Format
Online (77)
Mediatypes
Articles (Online) (48)
OpenAccess-fulltext (29)
Sorted by: Relevance
Sorted by: Year
?
1
Baseline characteristics of idiopathic hypersomnia subjects..:
Roth, T.
;
Rosenthal, L.
;
Avidan, A.
...
Sleep Medicine. 64 (2019) - p. S328 , 2019
Link:
https://doi.org/10.1016/..
?
2
Idiopathic hypersomnia symptom diary (IHSD): development of..:
Lam, M.C.
;
Dorenbaum, A.
;
Lien, L.
..
Sleep Medicine. 64 (2019) - p. S209 , 2019
Link:
https://doi.org/10.1016/..
?
3
Characteristics of subjects excluded form an idiopathic hyp..:
Roth, T.
;
Rosenthal, L.
;
Dorenbaum, A.
...
Sleep Medicine. 64 (2019) - p. S327-S328 , 2019
Link:
https://doi.org/10.1016/..
?
4
Are reports of mental fog from patients with idiopathic hyp..:
Roth, T.
;
Dorenbaum, A.
;
Jaros, M.
.
Sleep Medicine. 64 (2019) - p. S328 , 2019
Link:
https://doi.org/10.1016/..
?
5
Clarity: A Phase 2, Randomized, Double-Blind, Placebo-Contr..:
Mayo, M.J.
;
Pockros, P.
;
Jones, D.
...
Journal of Hepatology. 64 (2016) 2 - p. S197 , 2016
Link:
https://doi.org/10.1016/..
?
6
LO4 : A phase 2, randomized, placebo-controlled study (IMAG..:
Baker, A.
;
Kelly, D.
;
McClean, P.
...
Journal of Hepatology. 62 (2015) - p. S259 , 2015
Link:
https://doi.org/10.1016/..
?
7
Characterization and Predictors of Asthma Exacerbations in ..:
Calhoun, W.
;
Haselkorn, T.
;
Mink, D.R.
...
Journal of Allergy and Clinical Immunology. 129 (2012) 2 - p. AB73 , 2012
Link:
https://doi.org/10.1016/..
?
8
The response of patients with phenylketonuria and elevated ..:
Burton, B. K.
;
Grange, D. K.
;
Milanowski, A.
...
Journal of Inherited Metabolic Disease. 30 (2007) 5 - p. 700-707 , 2007
Link:
https://doi.org/10.1007/..
?
9
Pharmacokinetics of oral zidovudine administered during lab..:
Mirochnick, M
;
Rodman, JH
;
Robbins, BL
...
HIV Medicine. 8 (2007) 7 - p. 451-456 , 2007
Link:
https://doi.org/10.1111/..
?
10
502 Osteomyelitis in a patient with chronic granolomatous d..:
DORENBAUM, A
;
KLINE, M
;
ABRAMSON, S
...
Journal of Allergy and Clinical Immunology. 87 (1991) 1 - p. 265 , 1991
Link:
https://doi.org/10.1016/..
?
11
Mavodelpar, a selective peroxisome proliferator-activated r..:
Seminotti, Bianca
;
Adams, John
;
Dorenbaum, Alex
.
Molecular Genetics and Metabolism. 141 (2024) 4 - p. 108319 , 2024
Link:
https://doi.org/10.1016/..
?
12
Characterization of Fatigue in Primary Mitochondrial Myopat..:
Karaa, Amel
;
Johnson, Nathan
;
Clarkson, Ian
...
Neurology Clinical Practice. 14 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1212/..
?
13
Safety, tolerability, and efficacy of maralixibat in adults..:
Bowlus, Christopher L.
;
Eksteen, Bertus
;
Cheung, Angela C.
...
Hepatology Communications. 7 (2023) 6 - p. , 2023
Link:
https://doi.org/10.1097/..
?
14
Treatment of VLCAD-Deficient Patient Fibroblasts with Perox..:
D'Annibale, Olivia M.
;
Phua, Yu Leng
;
Van't Land, Clinton
...
Cells. 11 (2022) 17 - p. 2635 , 2022
Link:
https://doi.org/10.3390/..
?
15
Maralixibat for the treatment of PFIC: Long‐term, IBAT inhi..:
Loomes, Kathleen M.
;
Squires, Robert H.
;
Kelly, Deirdre
...
Hepatology Communications. 6 (2022) 9 - p. 2379-2390 , 2022
Link:
https://doi.org/10.1002/..
1-15